Last reviewed · How we verify

NCT05715489

Pectopexy Surgery Without Mesh

Completed NA Last updated 1 October 2024
What this trial tests

NA trial testing Comparison of pre and postoperative POP-Q values of the patients in Pelvic Organ Prolapse in 38 participants. Completed in 11 May 2024.

Timeline
11 May 2022
Primary endpoint
11 May 2024
11 May 2024

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment38
Start date11 May 2022
Primary completion11 May 2024
Estimated completion11 May 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 30 to 75, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

it is aimed to examine the effect of laparoscopic pectopexy surgery without mesh on Pelvic Organ Prolapse Measurement (POP-Q) and quality of life of the patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pelvic Organ Prolapse

Currently open trials in the same condition.

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05715489.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing